Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment

Por Fruci, Barbara, Giuliano, Stefania, Mazza, Angela, Malaguarnera, Roberta, Belfiore, Antonino
Publicado em 2013

The Role of Metformin in the Management of NAFLD

Por Mazza, Angela, Fruci, Barbara, Garinis, Giorgia Anna, Giuliano, Stefania, Malaguarnera, Roberta, Belfiore, Antonino
Publicado em 2012

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis

Por Vella, Veronica, Nicolosi, Maria Luisa, Giuliano, Stefania, Bellomo, Maria, Belfiore, Antonino, Malaguarnera, Roberta
Publicado no Front Endocrinol (Lausanne) (2017)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes

Por Mirabelli, Maria, Chiefari, Eusebio, Tocci, Vera, Caroleo, Patrizia, Giuliano, Stefania, Greco, Emanuela, Luque, Raul Miguel, Puccio, Luigi, Foti, Daniela Patrizia, Aversa, Antonio, Brunetti, Antonio
Publicado no J Clin Med (2021)

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes

Por Mirabelli, Maria, Chiefari, Eusebio, Caroleo, Patrizia, Arcidiacono, Biagio, Corigliano, Domenica Maria, Giuliano, Stefania, Brunetti, Francesco Saverio, Tanyolaç, Sinan, Foti, Daniela Patrizia, Puccio, Luigi, Brunetti, Antonio
Publicado no Int J Environ Res Public Health (2019)